Bristol-Myers Squibb Co. (BMY) to Acquire iPierian for for Up to $725M

April 29, 2014 7:19 AM

Bristol-Myers Squibb Co. (NYSE: BMY) acquired iPierian, a privately held biotechnology company focused on the discovery and development of new ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found